GBS Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
GBS Inc. - overview
Location
New York, NY, US
Primary Industry
Biotechnology
About
Based in New York, US, GBS Inc. operates as a manufacturer of Saliva Glucose Biosensor (SGB). The Saliva Glucose Biosensor is a non-invasive glucose test for diabetes treatment that monitors glucose in saliva rather than blood.
Primary Industry
Biotechnology
Sub Industries
Biotechnology
Website
www.gbs.inc
Verticals
Manufacturing
Total Amount Raised
Subscriber access only
GBS Inc. - timeline of key events
GBS Inc. - financials
| Fiscal Year Ended | Jun 30, 2021 | Jun 30, 2022 | Jun 30, 2023 |
|---|---|---|---|
| Revenue (USD) | - | - | - |
| % Revenue Growth (YoY) | - | - | - |
| EBITDA (USD) | - | - | - |
| Operating Income (USD) | - | - | - |
| Operating Margin | - | - | - |
| % EBITDA Margin | - | - | - |
| NET Income (USD) | - | - | - |
| % Net Margin | - | - | - |
GBS Inc. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.